Using drug-eluting balloons in coronary interventions from the perspective of the BASKET-SMALL 2 trial

Abstract

The authors present a review of the current options of using paclitaxel-coated drug-eluting balloons (DEBs). They discuss the options of treatment with this instrumentarium in managing in-stent restenosis as well as de novo lesions.

Main emphasis is placed on the recently published BASKET-SMALL 2 trial. Also discussed is the role of sirolimus-coated DEBs.

Keywords

• coronary stenoses
• drug-eluting balloons
• drug-eluting stents